INTRODUCTION
In developing countries like India, liver diseases continue to pose a significant health problem. The rise in the burden of chronic liver diseases and its complications has a huge impact on the economy. A serious neuropsychiatric disorder occurring in liver dysfunction patients in the absence of brain disease constitutes Hepatic encephalopathy. 1 In the recently reported WHO (World Health Organization) data, 2.95% of total deaths in India were caused by liver diseases deaths. 2 India was ranked 63 rd in the world when age-adjusted death rates (22.93 per 100,000 of population) were calculated. 2 Hepatic encephalopathy also known as portosystemic encephalopathy (PSE) is a reversible syndrome of impaired brain function occurring in advanced liver failure patients. 3 It is associated with poor survival and a high risk of recurrence and even in its mildest form, health-related quality of life is reduced drastically. 4 Subtle signs of HE are observed in nearly 70% of patients and overt hepatic encephalopathy occurs in about 30-45% of patients with cirrhosis. 5 In chronic liver diseases, normally, ammonia is produced by bacteria in the gastrointestinal tract due to breakdown of amines, amino acids, purines, and urea and it is followed by metabolism and clearance by the liver. But in cirrhosis or advanced liver dysfunction, there is either a decrease in the number of functioning hepatocytes or portosystemic shunting, or both resulting in impaired ability of liver to detoxify toxins and hyperammonemia. HE is characterized by a spectrum of neuropsychiatric abnormalities resulting from the accumulation of neurotoxic substances in the bloodstream and ultimately building up in the brain. The results of correlation of ammonia levels with grade of HE have been contradicting. 6, 7 Most episodes of HE in patients with cirrhosis are due to clinically apparent precipitating factors or the spontaneous development of portosystemic shunting. Common precipitating factors include gastrointestinal bleeding, infections, hypovolemia, azotemia, constipation, electrolyte imbalance, and high protein diet. Infections and GI bleeding were the most common precipitating factors documented in the literature. [8] [9] [10] [11] The development of encephalopathy in patients with chronic liver disease is a poor prognostic sign but this complication can be managed in the vast majority of patients as hepatic encephalopathy in cirrhosis is usually reversible. 12 However, patient outcome relies on early identification of the precipitating cause that caused deterioration. Hence, it is important to identify the precipitating cause and correct it early. In resource limited areas, most patients outcomes are poor and thought to be due to later stage presentation and limited treatment options. So, this study was carried out with the objective of determining the clinical profile of hepatic encephalopathy in cirrhosis of liver and identifying precipitating factors and its correlation with the outcome.
MATERIAL AND METHODS
A retrospective, case record-based study was done using case records of all patients aged 18 years and above admitted with clinical signs and symptoms of cirrhosis of liver with hepatic encephalopathy from January 2016 to December 2018 after the approval of Institute ethics committee. (Table 4) . Among all precipitating factors there was significant association between mortality in HE and haematemesis. All patients who expired belonged to class C according to Child Pugh score. Mortality rate of patients in class C is 20%. The difference in the proportion of duration of disease between mortality was statistically not significant (P value 0.69) (table-5).
DISCUSSION
Hepatic encephalopathy (HE) is a major complication of liver cirrhosis that leads to significant morbidity and mortality. Although the exact pathogenic mechanism is yet to be determined, in majority of patients with HE, a clearly definable precipitating factors can be identified and reversal or control of these factors is the key step in the management. In the present study, a total of 103 patients with cirrhosis of liver presenting with HE were included. Their clinical presentation, precipitating factors and their outcomes were recorded and analyzed. 60.19% had new onset H.E. while 39.81% had recurrent H.E. Clinically 39.81% presented with grade III H.E. while 36.89% presented with grade II H.E. 19.42% had grade IV H.E. at presentation compared to only 3.88% with grade I H.E. Dehydration was the most common (78.64%) precipitating factor followed by infections seen in 56.57% of the subjects (SBP-31%, UTI-1.94%, Respiratory infections -15.53%), diuretics (46.6%), hypokalemia (35.3%), constipation (33%) and G.I. bleeding in 30% of the subjects (hematemesis -15.53%, malena-14.56%).
There was significant association between mortality in HE and haematemesis in our study. But there was no significant association between mortality in HE with duration of disease, dehydration, infections and diuretics. In this study, majority of the study subjects were males (92.23%). The male preponderance is explained by the patterns of alcohol consumption in males. Similar male dominance was also reported by Iqbal J et al 14 and Kumar SKK et al. 10 The mean age of the subjects was 51.25 years in the study by Kumar SKK et al 10 similar to our study (49.58 ± 12.26) years. In our study, most of the subjects (56.31%) were aged between 41 to 60 years with the mean age of the study population at 49.58 (± 12.26) years. The mean age of the subjects was also 47 years in the study by Raphael KC et al. 15 45.63 % of our study subjects stayed in the hospital between 1 week to 3 weeks. Similarly Iqbal J et al 14 also reported a mean hospital stay duration of 11 days in their study. The mortality in our study was 17.48%. 57.28% recovered and were discharged. 10.68% got discharged against medical advice and 14.56% were referred. Similar to our study, Iqbal J et al 14 reported a mortality of 11.4 % in their study. The mortality rate was higher (23%) than our study in the study done by Devrajani BR et al 8 in Hyderabad. This higher mortality in their study compared to our study can be attributed to the difference in the severity of HE between the studies. In their study 80% had grade IV H.E. compared to only 19.42% at presentation in our study. The West Haven Criteria categorizes HE into 4 stages. Clinically 39.81% presented with grade III H.E. while 36.89% presented with grade II H.E. in our study with only 3.88% presenting with grade I H.E. In the study by Nayak M et al 9 , majority of the patients had higher grades of encephalopathy with 36% in grade IV, 30% in grade III, 10% in grade II, while24% had grade I HE. In the study by Kumar SKK et al 10 done in kerala, they also observed that most of the subjects had Grade 2 and 3 HE. With regards to severity of cirrhosis assessed by CTP scores, 87.38% of our study subjects fell under class C. In the study by Nayak M et al 9 also, majority (60 %) were in Class C followed by 24 % in Class A and only 16 % in Class B. Similarly Raphael KC et al 15 also reported that 77.3% of their subjects had class C CTP score. Hepatic encephalopathy (HE) is a major complication of endstage liver disease and acute liver failure. Overt HE (OHE) occurs in at least 30% to 45% of patients with cirrhosis as well as in 10% to 50% of patients who have undergone transjugular intrahepatic portosystemic shunt, and is one of the defining characteristics of acute liver failure. 16 The most common cause of cirrhosis of liver in our study was alcohol (88.35%). 4.85% of subjects had Hepatitis B while 0.97% had Hepatitis C infection and 2.9% had Hepatitis B infection besides being alcoholic. The most common cause in the study by Nayak M et al 9 was also alcohol (76%) followed by HBV (16%) and 
